Joint Position Statement

Electronic Signatures and Clinical Trial Research Agreement execution in Australia CT:IQ together with Medicines Australia (MA), Medical Technology Association of Australia (MTAA) and AusBiotech have released a joint position statement confirming that eSignatures can be used to execute clinical trial research agreements (CTRAs) in Australia. Read the statement below or access Joint Position Statement [PDF: […]

Illingworth Research Group joins Steering Committee

We are delighted to welcome Illingworth Research Group (Australia) Pty Ltd to CT:IQ’s Steering Committee.  Illingworth specialises in making clinical trial participation more accessible and convenient for patients and their carers by providing a range of patient centric services to the CRO, pharmaceutical, healthcare, biotechnology and medical device industries. As the only global specialist provider […]

Factory-CRO Group Announces New Name, Avania

This article was originally published on the Avania website Factory-CRO Group, a medical technology contract research organization (CRO) formed by the merger of BBA (Boston, U.S.), Factory CRO (Netherlands), Five Corners (Australia), and MileStone Research Organization (San Diego, U.S.), is pleased to announce its rebranding as Avania. Avania brings knowledgeable experts together to form a […]

CT:IQ launches Clinical Trial Site Recruitment Guide

CT:IQ has launched a practical tool to help research sites navigate the challenges of recruiting participants for clinical trials. The CT:IQ GREET project (Guidance to Recruitment Examining Experiences at Trial sites) identified barriers and enablers to recruitment at a site level and developed best practice recommendations in the form of the Clinical Trial Site Recruitment Guide. It is widely accepted and recognised that clinical […]

CT:IQ launches checklist to support Australian research sites

CT:IQ, a collaborative of Australian clinical trial stakeholders who aim to develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, is excited to launch the Early Phase Trials Best Practice Checklist. The checklist was developed as a single source of best practice recommendations, tools and resources to help ensure […]

A message from Leanne Weekes – CT:IQ Programme Director

Our priority is the safety and wellbeing of our talented staff, CT:IQ members, our stakeholders and their families in the current environment. Following the declaration of the COVID-19 (coronavirus) pandemic, CT:IQ have transitioned to a work from home arrangement for the time being. As part of the social distancing measures we are implementing, we now […]

CT:IQ Webinar

Join us for a free webinar on Wednesday 18 September with Praxis Australia and learn about CT:IQ’s clinical trial projects, future plans and the benefits of becoming a CT:IQ member. CT:IQ are conducting five projects in 2019 selected and prioritised against the needs of the sector by our Steering Committee members in the following areas: […]